Multiclass <scp>HCV</scp> resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapiesVelia Chiara Di Maio, Francesca Ceccherini‐Silberstein, Simona Landonio et al.|Liver International|2017Cited by 90
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsVelia Chiara Di Maio, Valeria Cento, M. Aragri et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 13
Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapiesVelia Chiara Di Maio, M. Paoloni, Valeria Cento et al.|Journal of Hepatology|2017Cited by 2
The challenge of HCV-retreatment after DAA-failure: real-life experience advocates for cautionValeria Cento, Francesca Ceccherini‐Silberstein, Silvia Barbaliscia et al.|Journal of Hepatology|2017Cited by 1
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapiesVelia Chiara Di Maio, Valeria Pace Palitti, Valeria Cento et al.|Digestive and Liver Disease|2017Cited by 1